Japan’s CellSeed Develops Regenerative Treatment For Tooth Disease
This article was originally published in PharmAsia News
Executive Summary
Japanese biotech CellSeed has developed the first technology relying on regenerative medicine to treat periodontal disease. CellSeed is collaborating with Tokyo Women's Medical University on the project, with expectations of having the technology in clinical trials in 2013. The technique involves regenerating the periodontal membrane that surrounds the root of a tooth. (Click here for more - a subscription may be required